The Claim
In mice fed a high-fat diet, treatment with the PPARβ/δ activator GW501516 prevents the down-regulation of AMP-activated protein kinase (AMPK) phosphorylation in the liver, suggesting a potential mechanism by which GW501516 supports metabolic regulation under dietary stress.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In mice eating a bad diet, a drug called GW501516 might help keep a key energy-sensing switch in the liver working properly, which could help their bodies handle the stress of unhealthy eating.
See the scientific wording
In mice fed a high-fat diet, treatment with the PPARβ/δ activator GW501516 is associated with prevention of the down-regulation of AMP-activated protein kinase (AMPK) phosphorylation in the liver, suggesting a potential mechanism by which GW501516 supports metabolic regulation under dietary stress.
What the research says
1 studyThe study shows that giving GW501516 to mice on a high-fat diet keeps an important energy-sensing protein (AMPK) active in the liver, which matches what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.